MHRA Class 4 Medicines Defect Information: Liothyronine Sodium 5 & 20 micrograms Tablets (Strides Pharma UK Ltd)
MHRA Class 4 Medicines Defect Information: Liothyronine Sodium 5 & 20 micrograms Tablets (Strides Pharma UK Ltd) Drug alert number: EL (24)A/58 Date issued: 28 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Liothyronine Sodium 5 & 20 micrograms Tablets (Strides Pharma UK [...]
The post MHRA Class 4 Medicines Defect Information: Liothyronine Sodium 5 & 20 micrograms Tablets (Strides Pharma UK Ltd) appeared first on Community Pharmacy England.
Recent Comments